Earnings Pressure and the Loss Reserve Estimate
Coastal Specialty's carried IBNR is $410 million, equal to the actuary's central estimate. The actuarial range is $390 million to $440 million. With two days left in the quarter, the CFO tells the chief actuary to book $395 million so the company meets the analyst EPS consensus; missing it would, the CFO says, 'cost us the rating.' The change would reduce incurred losses by $15 million, about 25% of expected net income. Last year the company reported $12 million of adverse development. The audit committee has asked for a memo on the request.
1. Evaluate whether booking $395 million is acceptable.
Read the worked answer
Booking $395 million is not acceptable on the facts presented. The actuary's central estimate is $410 million, and the range is $390 million to $440 million. A range is not a selection menu; the recorded estimate should reflect the actuary's best estimate of ultimate losses. Moving to $395 million solely to meet an EPS consensus is earnings management, not an actuarial judgement. The $15 million change is material at about 25% of expected net income, and last year's $12 million of adverse development is a warning that the prior estimates may already have been optimistic. If new claim information genuinely supported $395 million, the actuary could document that evidence and revise the central estimate, but the CFO's stated motivation is irrelevant and improper. The request should be refused.
2. What controls, disclosures, and escalation should follow?
Read the worked answer
The actuary should refuse the request in writing, document the conversation and the actuarial basis for $410 million in the actuarial file, and escalate the matter to the audit committee and, if necessary, the board. The audit committee should ask whether there has been any actual change in claims experience, whether the CFO's pressure affected other estimates, and whether internal controls over financial reporting are adequate. The company should disclose the reserve estimate, the range, the prior-year development, and any change in estimate in the financial statements and management discussion. The external auditor and, if applicable, the independent actuarial reviewer should be informed. If the CFO persists or retaliation occurs, the actuary should follow the company's ethics hotline and applicable actuarial standards, which require integrity and objectivity. The quarter-end close should not be used to reverse a well-supported estimate.
3. How should the board analyze the CFO's argument that missing consensus will 'cost us the rating'?
Read the worked answer
The board should reject the premise that a rating can be protected by understating reserves. Rating agencies assess capital adequacy, reserve strength, earnings quality, and management credibility. A $15 million reduction that is reversed by adverse development next year would weaken, not protect, the rating, and it would create securities and regulatory exposure. The board should compare the near-term EPS benefit with the cost of a restatement, a reserve strengthening, and loss of market confidence. If the rating is genuinely at risk, the appropriate responses are capital raising, reinsurance, expense reduction, or a credible strategic plan, not a change in the reserve estimate. The board should also review whether the CFO's compensation or pressure from the parent created an incentive to manage earnings, and it should reinforce a culture in which the actuary reports to the board or audit committee without fear of retaliation.